UpHealth (UPH) & Its Rivals Head to Head Analysis

UpHealth (NYSE:UPHGet Rating) is one of 33 publicly-traded companies in the “Health services” industry, but how does it contrast to its rivals? We will compare UpHealth to similar businesses based on the strength of its profitability, risk, valuation, analyst recommendations, dividends, institutional ownership and earnings.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for UpHealth and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UpHealth 0 1 1 0 2.50
UpHealth Competitors 7 130 274 0 2.65

UpHealth presently has a consensus price target of $3.50, indicating a potential upside of 856.28%. As a group, “Health services” companies have a potential upside of 117.12%. Given UpHealth’s higher probable upside, equities analysts plainly believe UpHealth is more favorable than its rivals.

Insider & Institutional Ownership

48.6% of shares of all “Health services” companies are owned by institutional investors. 41.3% of UpHealth shares are owned by insiders. Comparatively, 21.6% of shares of all “Health services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares UpHealth and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
UpHealth $123.79 million -$340.90 million -0.16
UpHealth Competitors $1.36 billion -$98.47 million 29.16

UpHealth’s rivals have higher revenue and earnings than UpHealth. UpHealth is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

UpHealth has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500. Comparatively, UpHealth’s rivals have a beta of 1.48, indicating that their average share price is 48% more volatile than the S&P 500.

Profitability

This table compares UpHealth and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
UpHealth -204.99% -18.80% -11.75%
UpHealth Competitors -325.87% -481.74% -38.64%

Summary

UpHealth rivals beat UpHealth on 7 of the 12 factors compared.

About UpHealth

(Get Rating)

UpHealth, Inc. operates as a digital health services company. It provides a patient-centric digital health technologies and tech-enabled services to manage health and integrate care in the areas of integrated care management, virtual care infrastructure, and services. The company's solutions include Syntranet Core Platform, an integrated care management platform; Cloudbreak, a provider of unified telemedicine solutions and digital health tools; HelloLyf from Glocal, a platform that delivers primary care and specialty consultations; and MedQuest Pharmacy, a full-service retail and compounding licensed pharmacy that dispenses prescribed medications shipped directly to patients. UpHealth, Inc. is headquartered in Delray Beach, Florida.

Receive News & Ratings for UpHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UpHealth and related companies with MarketBeat.com's FREE daily email newsletter.